| MDN1 |
MDN1, KIAA0301: Midasin |
PHF11 |
RP11-185C18.3, PHF11, RP11-185C18.3-001, hCG_28346: OTTHUMP00000018414 |
0.253 |
Evidence |
|
| FXR2 |
FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 |
WIRE |
WIPF2, WICH, PP10631, WIRE: WAS/WASL-interacting protein family member 2 |
0.253 |
Evidence |
|
| ERCC1 |
ERCC1: DNA excision repair protein ERCC-1 |
ERCC2 |
ERCC2, XPD, XPDC: TFIIH basal transcription factor complex helicase subunit |
0.253 |
Evidence |
|
| MCM6 |
MCM6: DNA replication licensing factor MCM6 |
ORC3L |
ORC3L, LATHEO: Origin recognition complex subunit 3 |
0.253 |
Evidence |
|
| YY1 |
YY1: Transcriptional repressor protein YY1 |
HIF1AN |
HIF1AN, FIH1: Hypoxia-inducible factor 1 alpha inhibitor |
0.253 |
Evidence |
|
| AP4M1 |
AP4M1, MUARP2: AP-4 complex subunit mu-1 |
AP2M1 |
AP2M1, CLAPM1, KIAA0109: AP-2 complex subunit mu-1 |
0.253 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
0.253 |
Evidence |
|
| RPL18A |
RPL18A: 60S ribosomal protein L18a |
NSD1 |
NSD1, ARA267: Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 |
0.253 |
Evidence |
|
| BIRC1 |
BIRC1, NAIP: Baculoviral IAP repeat-containing protein 1 |
EIF2B1 |
EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha |
0.253 |
Evidence |
|
| SH3GL3 |
IPI00216202 |
DNALI1 |
DNALI1: Axonemal dynein light intermediate polypeptide 1 |
0.253 |
Evidence |
|
| DDX3X |
DDX3X, DBX, DDX3: ATP-dependent RNA helicase DDX3X |
CKS2 |
CKS2: Cyclin-dependent kinases regulatory subunit 2 |
0.253 |
Evidence |
|
| RPS5 |
RPS5: 40S ribosomal protein S5 |
VDAC3 |
VDAC3: Voltage-dependent anion-selective channel protein 3 |
0.253 |
Evidence |
|
| HPN |
HPN, TMPRSS1: Serine protease hepsin |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
0.25 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.25 |
Evidence |
|
| LPA |
LPA: Apolipoprotein(a) precursor |
MBL2 |
MBL2, MBL: Mannose-binding protein C precursor |
0.25 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
FGB |
FGB: Fibrinogen beta chain precursor [Contains: Fibrinopeptide B] |
0.25 |
Evidence |
|
| SRF |
SRF: Serum response factor |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
0.25 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
0.25 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
DAXX |
DAXX, BING2, DAP6: Death domain-associated protein 6 |
0.25 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
GPR44 |
GPR44, CRTH2, DL1R: Putative G-protein coupled receptor 44 |
0.25 |
Evidence |
|
| MTNR1B |
MTNR1B: Melatonin receptor type 1B |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.25 |
Evidence |
|
| GALR3 |
GALR3, GALNR3: Galanin receptor type 3 |
CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
0.25 |
Evidence |
|
| IFNA6 |
IFNA6: Interferon alpha-6 precursor |
IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
0.25 |
Evidence |
|
| BMPR1A |
BMPR1A, ACVRLK3, ALK3: Bone morphogenetic protein receptor type IA precursor |
GDF10 |
GDF10, BMP3B: Bone morphogenetic protein 3b precursor |
0.25 |
Evidence |
|
| TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
AIM2 |
AIM2: AIM2 protein |
0.25 |
Evidence |
|
- 
-